Vimarsana
Biggest News Aggregation in the World

Linlin Yang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linlin Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linlin Yang Today - Breaking & Trending Today

Yeahka Limited (YHEKF) Q2 2022 Earnings Call Transcript - Vimarsana News

Yeahka Limited (YHEKF) Q2 2022 Earnings Call Transcript

Yeahka Limited (OTCPK:YHEKF) Q2 2022 Earnings Conference Call August 30, 2022 8:00 A.M.

Kingsoft Corporation Limited (KSFTF) CEO Tao Zou on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Kingsoft Corporation Limited (KSFTF) CEO Tao Zou on Q1 2022 Results - Earnings Call Transcript

Kingsoft Corporation Limited (OTCPK:KSFTF) Q1 2022 Earnings Conference Call May 24, 2022 7:00 AM ET Company Participants Francie Lu - IR Tao Zou - CEO Francis Ng - CFO Conference Call...

Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies - Vimarsana News

Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies

 E-Mail IMAGE: A researcher at Calibr, the drug discovery division of Scripps Research, working in the high-throughput screening facility used to identify potential COVID-19 therapies. view more  Credit: Scripps Research June 3, 2021 - LA JOLLA, CA--Mining the world's most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that's driving the ongoing global pandemic. Among those compounds, the Scripps Research study identified four clinically approved drugs a...

Versatile coronavirus antibody may be starting point for broader-acting vaccines - Vimarsana News

Versatile coronavirus antibody may be starting point for broader-acting vaccines

 E-Mail LA JOLLA, CA--Even before the COVID-19 pandemic, most people in the United States already had been sick with a coronavirus, albeit a far less dangerous one. That's because at least four coronaviruses in the same general family as SARS-CoV-2 cause the benign yet annoying illness known as the common cold. In a new study that appears in Nature Communications, scientists from Scripps Research investigated how the immune system's previous exposure to cold-causing coronaviruses impact immune response to COVID-19. In doing so, they discovered one cross-reactive coronavirus antibody that's...